EcoDrugPlus

Neuropeptide Y Receptor Y4-2

Ensembl ID : ENSECRG00000007981
Gene Symbol: NPY4R2
3 Cross references
116 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSECRG00000007816
Gene Symbol: NPY5R
1 Cross references
137 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSECRG00000013239
Gene Symbol: NTSR1
1 Cross references
207 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSECRG00000001249
Gene Symbol: NTRK1
3 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSECRG00000005951
Gene Symbol: NTRK2
3 Cross references
288 Possible Orthologues:

Neutrophil Collagenase-Like

Ensembl ID : ENSECRG00000003327
Gene Symbol: LOC114650497
2 Cross references
173 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2a

Ensembl ID : ENSECRG00000007884
Gene Symbol: NFE2L2A
1 Cross references
216 Possible Orthologues:

Nicastrin

Ensembl ID : ENSECRG00000015410
Gene Symbol: NCSTN
3 Cross references
204 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSECRG00000003323
Gene Symbol: NAMPT
3 Cross references
220 Possible Orthologues:

Nischarin

Ensembl ID : ENSECRG00000022245
Gene Symbol: NISCH
3 Cross references
210 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSECRG00000006882
Gene Symbol: NOS2
3 Cross references
168 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSECRG00000012560
Gene Symbol: NOTCH1
3 Cross references
269 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).